Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian, or Tagalog
Who may not be able to join:
- People who are experiencing significant eye pain
- People who have had a sudden decrease in their vision within the past week
- People who are experiencing double vision when using both eyes together
- People who have a cognitive impairment (a condition affecting thinking, memory, or understanding)
- People who are pregnant
- People who have previously been asked to take part in this trial and declined
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paula Anne Newman-Casey, MD, University of Michigan
Phone: 734-763-6967
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy); Rate of glaucoma/suspected glaucoma; Rate of visually significant cataract; Rate of diabetic retinopathy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.